Calendar Percheron Therapeutics Limited Börse Stuttgart

Equities

AWY0

AU0000317281

Delayed Börse Stuttgart 07:05:24 27/06/2024 BST 5-day change 1st Jan Change
0.0485 EUR +1.25% Intraday chart for Percheron Therapeutics Limited -3.23% +39.24%

Chart calendar Percheron Therapeutics Limited

c178b3ad55f348.jUckXFpRa4gJOKj9WKz-6GaJ_gMaRfdGQFwNWCWemII.3iZwais4P99ifcGJL8-TiQzBp0FUAsUIFTh4Phb_2ercMW4tG2gbymZB7Q~b67b802a5c599085a4f8a92973ee86d6

Upcoming events on Percheron Therapeutics Limited

27/08/2024 Q4 2024 Earnings Release (Projected)
25/02/2025 Q2 2025 Earnings Release (Projected)
26/08/2025 Q4 2025 Earnings Release (Projected)
03/03/2026 Q2 2026 Earnings Release (Projected)

Past events on Percheron Therapeutics Limited

02/06/2024 Bio International Convention
29/04/2024 23:53 March 2024 Sales and Revenue Release - Activities Report
02/03/2024 Muscular Dystrophy Association Clinical and Scientific Conference - Poster No - V410
02/03/2024 Muscular Dystrophy Association Clinical and Scientific Conference - Poster No - V409
02/03/2024 Muscular Dystrophy Association Clinical and Scientific Conference - Poster No - M149
28/02/2024 06:20 Q2 2024 Earnings Release
30/01/2024 22:12 December 2023 Sales and Revenue Release - Activities Report
07/01/2024 JPMorgan Healthcare Conference
07/01/2024 Biotech Showcase
15/11/2023 03:00 Annual General Meeting
31/10/2023 AusBiotech Conference
30/10/2023 22:38 September 2023 Sales and Revenue Release - Activities Report
17/10/2023 21:45 BIO Investor Forum
08/09/2023 05:00 ShareCafe Small Cap Hidden Gems Conference
25/08/2023 09:08 Q4 2023 Earnings Release
28/07/2023 00:37 June 2023 Sales and Revenue Release - Activities Report
17/04/2023 00:38 March 2023 Sales and Revenue Release - Activities Report
22/02/2023 05:24 Interim 2023 Earnings Release
24/01/2023 December 2022 Sales and Revenue Release - Activities Report
17/11/2022 03:00 Annual General Meeting

Annual results

Fiscal PeriodJune 2020 2021 2022 2023 2024
Net sales
Million AUD
Released
Forecast
Spread
0,77


0,64
6,30
-89.89%
1,81
1,40
29.41%
1,96
1,80
9.15%

3,60

EBITDA
Million AUD
Released
Forecast
Spread
0,00


-7,95
-8,88
10.49%
-5,71
-11,3
49.31%
-11,3
-12,1
7.07%

-13,2

EBIT
Million AUD
Released
Forecast
Spread
0,00


-8,05
-8,87
9.28%
-5,80
-11,3
48.6%
-11,4
-12,2
6.66%

-13,3

Earnings before Tax (EBT)
Million AUD
Released
Forecast
Spread
0,00


-8,06
-8,20
1.7%
0,00
0,00
-
-11,4
-8,80
-29.32%

-17,2

Net income
Million AUD
Released
Forecast
Spread
0,00


-8,06
-8,96
10.02%
0,00
0,00
-
-11,4
-11,9
4.72%

-13,1

EPS
AUD
Released
Forecast
Spread
0,00


-0,01
-0,02
6.88%
0,00
0,00
-
-0,02
-0,02
4.39%

-0,02

Announcement Date26/08/2025/08/2131/08/2225/08/23-

Quarterly results

Fiscal PeriodJune 2021 S2 2024 S1
Net sales
Million AUD
Released
Forecast
Spread



1,20
0,00
-
EBITDA
Million AUD
Released
Forecast
Spread
-6,01
-6,00
-0.17%
-4,69
-8,50
44.78%
EBIT
Million AUD
Released
Forecast
Spread
-6,01
-6,00
-0.17%
-4,74
-8,50
44.23%
Net income
Million AUD
Released
Forecast
Spread



-4,74
-8,60
44.85%
EPS
AUD
Released
Forecast
Spread



-0,01
-0,01
40%
Announcement Date25/08/2128/02/24

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PER Stock
  4. AWY0 Stock
  5. Calendar Percheron Therapeutics Limited